Cargando…

Anti-cancer Activity of Novel TM4SF5-Targeting Antibodies through TM4SF5 Neutralization and Immune Cell-Mediated Cytotoxicity

The transmembrane four L6 family member 5 (TM4SF5) protein is a novel molecular target for the prevention and treatment of hepatocellular carcinoma. TM4SF5 is highly expressed in liver, colon, esophageal, and pancreatic cancers and is implicated in tumor progression. Here, we screened monoclonal ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, Hye-Mi, Ryu, Jihye, Song, Jin Myeong, Lee, Yunhee, Kim, Hye-Jin, Ko, Dongjoon, Choi, Inpyo, Kim, Sang Jick, Lee, Jung Weon, Kim, Semi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327636/ https://www.ncbi.nlm.nih.gov/pubmed/28255353 http://dx.doi.org/10.7150/thno.15629

Ejemplares similares

TM4SF5-Mediated Roles in the Development of Fibrotic Phenotypes
por: Ryu, Jihye, et al.
Publicado: (2017)

Therapeutic effects of TM4SF5-targeting chimeric and humanized monoclonal antibodies in hepatocellular and colon cancer models
por: Ko, Dongjoon, et al.
Publicado: (2022)

Membrane Proteins Involved in Epithelial-Mesenchymal Transition and Tumor Invasion: Studies on TMPRSS4 and TM4SF5
por: Kim, Semi, et al.
Publicado: (2014)

TM4SF5-mediated liver malignancy involves NK cell exhaustion-like phenotypes
por: Sun, Hyunseung, et al.
Publicado: (2021)

Correlations between Transmembrane 4 L6 Family Member 5 (TM4SF5), CD151, and CD63 in Liver Fibrotic Phenotypes and Hepatic Migration and Invasive Capacities
por: Kang, Minkyung, et al.
Publicado: (2014)

Amino acid transporters as tetraspanin TM4SF5 binding partners
por: Jung, Jae Woo, et al.
Publicado: (2020)

Targeting TM4SF5 with anti-TM4SF5 monoclonal antibody suppresses the growth and motility of human pancreatic cancer cells
por: Park, Sangkyu, et al.
Publicado: (2020)

TM4SF5-mediated protein-protein networks and tumorigenic roles
por: Lee, Jung Weon
Publicado: (2014)

Systemic TM4SF5 overexpression in Apc(Min/+) mice promotes hepatic portal hypertension associated with fibrosis
por: Lee, Joohyeong, et al.
Publicado: (2022)

TM4SF5-Mediated Regulation of Hepatocyte Transporters during Metabolic Liver Diseases
por: Kim, Ji Eon, et al.
Publicado: (2022)

Three Members of Transmembrane-4-Superfamily, TM4SF1, TM4SF4, and TM4SF5, as Emerging Anticancer Molecular Targets against Cancer Phenotypes and Chemoresistance
por: Rahim, Nur Syafiqah, et al.
Publicado: (2023)

N-terminus-independent activation of c-Src via binding to a tetraspan(in) TM4SF5 in hepatocellular carcinoma is abolished by the TM4SF5 C-terminal peptide application
por: Song, Haeng Eun, et al.
Publicado: (2021)

TM4SF5 promotes metastatic behavior of cells in 3D extracellular matrix gels by reducing dependency on environmental cues
por: Song, Dae-Geun, et al.
Publicado: (2017)

Crosstalk between TM4SF5 and GLUT8 regulates fructose metabolism in hepatic steatosis
por: Lee, Hyejin, et al.
Publicado: (2022)

Down-regulation of TM4SF is associated with the metastatic potential of gastric carcinoma TM4SF members in gastric carcinoma
por: Chen, Zhouxun, et al.
Publicado: (2011)

Liver‐originated small extracellular vesicles with TM4SF5 target brown adipose tissue for homeostatic glucose clearance
por: Jung, Jae Woo, et al.
Publicado: (2022)

Self-renewal and circulating capacities of metastatic hepatocarcinoma cells required for collaboration between TM4SF5 and CD44
por: Lee, Doohyung, et al.
Publicado: (2015)

TM4SF5 Knockout Protects Mice From Diet-Induced Obesity Partly by Regulating Autophagy in Adipose Tissue
por: Choi, Cheoljun, et al.
Publicado: (2021)

TM4SF5-mediated abnormal food-intake behavior and apelin expression facilitate non-alcoholic fatty liver disease features
por: Pinanga, Yangie Dwi, et al.
Publicado: (2023)

TM4SF5-mediated CD44v8-10 splicing variant promotes survival of type II alveolar epithelial cells during idiopathic pulmonary fibrosis
por: Kim, Ji Eon, et al.
Publicado: (2019)

Therapeutic effect of a TM4SF5-specific peptide vaccine against colon cancer in a mouse model
por: Kwon, Sanghoon, et al.
Publicado: (2014)

Therapeutic effect of a TM4SF5-specific monoclonal antibody against colon cancer in a mouse model
por: Kim, Young-Eun, et al.
Publicado: (2014)

TM4SF4 and LRRK2 Are Potential Therapeutic Targets in Lung and Breast Cancers through Outlier Analysis
por: Jung, Kyungsoo, et al.
Publicado: (2021)

Prevention and Therapy of Hepatocellular Carcinoma by Vaccination with TM4SF5 Epitope-CpG-DNA-Liposome Complex without Carriers
por: Kwon, Sanghoon, et al.
Publicado: (2012)

TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo
por: Cao, Jia, et al.
Publicado: (2015)

TM4SF18 is aberrantly expressed in pancreatic cancer and regulates cell growth
por: Singhal, Megha, et al.
Publicado: (2019)

Myeloid TM6SF2 Deficiency Inhibits Atherosclerosis
por: Zhu, Wenzhen, et al.
Publicado: (2022)

Anti-metastatic effect of the TM4SF5-specific peptide vaccine and humanized monoclonal antibody on colon cancer in a mouse lung metastasis model
por: Wu, Guang, et al.
Publicado: (2016)

Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer
por: Peng, Xing‐Chun, et al.
Publicado: (2018)

TM4SF1 is a potential target for anti-invasion and metastasis in ovarian cancer
por: Gao, Caiyun, et al.
Publicado: (2019)

TM4SF1 Promotes Proliferation, Invasion, and Metastasis in Human Liver Cancer Cells
por: Huang, Yu-Kun, et al.
Publicado: (2016)

Lateral habenula dysfunctions in Tm4sf2(−/y) mice model for neurodevelopmental disorder
por: Murru, Luca, et al.
Publicado: (2021)

TM9SF4 is an F-actin disassembly factor that promotes tumor progression and metastasis
por: Meng, Zhaoyue, et al.
Publicado: (2022)

Prognostic significance of TM4SF1 and DDR1 expression in epithelial ovarian cancer
por: Huang, Zhijiong, et al.
Publicado: (2023)

TM4SF4 overexpression in radiation-resistant lung carcinoma cells activates IGF1R via elevation of IGF1
por: Choi, Soo-Im, et al.
Publicado: (2014)

TM4SF1 Promotes Metastasis of Pancreatic Cancer via Regulating the Expression of DDR1
por: Yang, Jia-chun, et al.
Publicado: (2017)

TM9SF4 expression in tumor tissues: a novel diagnostic biomarker for gastrointestinal tumors
por: Guazzi, Paolo, et al.
Publicado: (2020)

TM9SF4 Is a Crucial Regulator of Inflammation and ER Stress in Inflammatory Bowel Disease
por: Xie, Mingxu, et al.
Publicado: (2022)

Targeting TM4SF1 exhibits therapeutic potential via inhibition of cancer stem cells
por: Chen, Guang, et al.
Publicado: (2022)

TM4SF1-AS1 inhibits apoptosis by promoting stress granule formation in cancer cells
por: Kitajima, Hiroshi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v48c92pn2idro5ksp0ptlft14c